Cargando…
O-Acetyl-GD2 as a Therapeutic Target for Breast Cancer Stem Cells
SYNOPSIS: A sugar-lipid molecule called OAcGD2 is a novel marker for breast cancer stem cells. Treatment with anti-OAcGD2 mAb8B6 may have superior anticancer efficacy by targeting cancer stem cells, thereby reducing metastasis and recurrence of cancer. BACKGROUND: Cancer stem cells (CSCs) that drive...
Autores principales: | Cheng, Jing-Yan, Hung, Jung-Tung, Lin, Juway, Lo, Fei-Yun, Huang, Jing-Rong, Chiou, Shih-Pin, Wang, Ya-Hui, Lin, Ruey-Jen, Wu, Jen-Chine, Yu, John, Yu, Alice L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8761789/ https://www.ncbi.nlm.nih.gov/pubmed/35046949 http://dx.doi.org/10.3389/fimmu.2021.791551 |
Ejemplares similares
-
The Multifaceted Effects of Polysaccharides Isolated from Dendrobium huoshanense on Immune Functions with the Induction of Interleukin-1 Receptor Antagonist (IL-1ra) in Monocytes
por: Lin, Juway, et al.
Publicado: (2014) -
Interaction of glycosphingolipids GD3 and GD2 with growth factor receptors maintains breast cancer stem cell phenotype
por: Liang, Yuh-Jin, et al.
Publicado: (2017) -
FAM129B, an antioxidative protein, reduces chemosensitivity by competing with Nrf2 for Keap1 binding
por: Cheng, Kai-Chun, et al.
Publicado: (2019) -
Co-Delivery of CPT-11 and Panobinostat with Anti-GD2 Antibody Conjugated Immunoliposomes for Targeted Combination Chemotherapy
por: Jose, Gils, et al.
Publicado: (2020) -
O-acetylation of Gd3: An Enigmatic Modification Regulating Apoptosis?
por: Chen, Helen Y., et al.
Publicado: (2002)